Innate Pharma S.A. IPHA

Full chart Compare
Set alert

Price alert · IPHA

All alert types
1.43 USD +0.08 (+5.93%)

Nov 4, 2026, 11:19 AM EST

1.40 Day range 1.42
1.17 52-week range 2.71
YTD
-18.29%
1 year
-22.28%

Revenue & Expenses

Other Income → Expenses: $4.25MExpenses → Selling, General & Admin: $11.00MExpenses → Research & Development: $43.62MExpenses → Other Operating Expenses: $1.59MGross Profit → Expenses: $2.79MRevenue → Gross Profit: $2.79MNet Loss → Expenses: $49.18MOther Income$4.25MGross Profit$2.79MNet Loss$49.18MExpenses$56.21MSelling, General & Admin$11.00MResearch & Development$43.62MOther Operating Expenses$1.59MRevenue$2.79M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

IPHA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
9.01M20.12M61.64M57.67M24.70M
10.58M20.94M68.23M61.48M27.98M
9.01M20.12M61.64M57.67M24.70M
63.01M71.70M74.31M115.10M72.53M
43.62M51.98M56.02M51.66M47.00M
19.39M19.72M18.29M22.44M25.52M
-54.01M-51.58M-12.67M-57.42M-47.83M
3.12M3.98M1.83M5.32M4.00M
-49.18M-49.47M-7.57M-58.10M-52.81M
-49.18M-49.47M-7.57M-58.10M-52.81M
-57.77M-51.48M-8.38M-61.94M-59.81M
-49.18M-49.47M-7.57M-58.10M-52.81M
-0.55-0.61-0.09-0.73-0.66
-0.646-0.635-0.10-0.778-0.747
-0.55-0.61-0.09-0.73-0.66
-46.06M-45.50M-5.74M-52.78M-48.81M
-54.10M-47.34M-6.35M-56.27M-55.28M
86.94M80.97M80.52M79.89M79.03M